Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-013992
Filing Date
2022-05-16
Accepted
2022-05-16 17:41:15
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2652
  Complete submission text file 0001493152-22-013992.txt   3991
Mailing Address 265 EAST 66TH STREET SUITE 16G NEW YORK NY 10021
Business Address
CERRONE GABRIELE M (Reporting) CIK: 0001139306 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41386 | Film No.: 22931303

Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Issuer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)